Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.27
-1.08 (-3.81%)
Aug 5, 2026, 11:26 AM EDT - Market open

Beam Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
156.04139.7463.52377.7160.9251.84
Revenue Growth
158.89%120.01%-83.18%520.01%17.51%215916.67%
Gross Profit
156.04139.7463.52377.7160.9251.84
Operating Income
-378.02-383.69-415.57-176.49-338.48-392.47
Net Income
-85.43-79.99-376.74-132.53-289.09-370.64
Earnings Per Share
-0.86-0.81-4.58-1.72-4.13-5.77
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,1531,245850.741,1901,078965.65
Total Debt
247.36154.12161.43172.69179.01147.64
Net Cash (Debt)
905.571,091689.321,017899.13818
Net Cash Growth
-9.04%58.29%-32.23%13.13%9.92%325.98%
Net Cash Per Share
8.7311.038.3713.1812.8412.74

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-359.38-345.1-347.25-149.222.53-66.27
Capital Expenditures
-13.39-14.95-8.95-33.73-48.95-46.81
Free Cash Flow
-372.77-360.05-356.19-182.93-26.42-113.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-242.27%-274.57%-654.25%-46.73%-555.61%-757.01%
Pretax Margin
-218.56%-57.24%-593.06%-34.73%-427.08%-714.91%
Profit Margin
-54.75%-57.24%-593.13%-35.09%-474.54%-714.91%
FCF Margin
-238.90%-257.65%-560.77%-48.43%-43.37%-218.11%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.7820.1832.655.8845.76105.12